Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Beam

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Scientific Reports|January 22, 2020
Synchronization of the Normal Human Peripheral Immune System: A Comprehensive Circadian Systems Immunology AnalysisCraig A Beam, Clive Wasserfall, Alyssa Woodwyk, et al.
Archives of Family Medicine|June 1, 1995
Surrogates' predictions of seriously ill patients' resuscitation preferencesP M Layde, C A Beam, S K Broste, et al.
Reproductive Toxicology (Elmsford, N.Y.)|December 21, 2011
Zebrafish developmental screening of the ToxCast™ Phase I chemical libraryS Padilla, D Corum, B Padnos, et al.
Investigative Radiology|February 1, 1993
Magnetic resonance imaging of blood flow with a phase subtraction technique. In vitro and in vivo validationA J Evans, F Iwai, T A Grist, et al.
The Journal of Clinical Investigation|February 3, 2015
β cell death and dysfunction during type 1 diabetes development in at-risk individualsKevan C Herold, Sahar Usmani-Brown, Tara Ghazi, et al.
Diabetes|July 19, 2013
Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participantsJay M Sosenko, Jay S Skyler, Craig A Beam, et al.
Cancer Research|November 25, 2003
Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line modelLori A Hazlehurst, Steven A Enkemann, Craig A Beam, et al.
Diabetes Care|July 3, 2013
The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patientsJay M Sosenko, Jay S Skyler, Jerry P Palmer, et al.
Diabetes Care|June 18, 2011
Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History StudyJay M Sosenko, Jay S Skyler, Jeffrey Mahon, et al.
Diabetes Care|May 2, 2012
The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetesJay M Sosenko, Jay S Skyler, Jeffrey Mahon, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Scientific Reports|January 22, 2020
Synchronization of the Normal Human Peripheral Immune System: A Comprehensive Circadian Systems Immunology AnalysisCraig A Beam, Clive Wasserfall, Alyssa Woodwyk, et al.
Archives of Family Medicine|June 1, 1995
Surrogates' predictions of seriously ill patients' resuscitation preferencesP M Layde, C A Beam, S K Broste, et al.
Reproductive Toxicology (Elmsford, N.Y.)|December 21, 2011
Zebrafish developmental screening of the ToxCast™ Phase I chemical libraryS Padilla, D Corum, B Padnos, et al.
Investigative Radiology|February 1, 1993
Magnetic resonance imaging of blood flow with a phase subtraction technique. In vitro and in vivo validationA J Evans, F Iwai, T A Grist, et al.
The Journal of Clinical Investigation|February 3, 2015
β cell death and dysfunction during type 1 diabetes development in at-risk individualsKevan C Herold, Sahar Usmani-Brown, Tara Ghazi, et al.
Diabetes|July 19, 2013
Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participantsJay M Sosenko, Jay S Skyler, Craig A Beam, et al.
Cancer Research|November 25, 2003
Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line modelLori A Hazlehurst, Steven A Enkemann, Craig A Beam, et al.
Diabetes Care|July 3, 2013
The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patientsJay M Sosenko, Jay S Skyler, Jerry P Palmer, et al.
Diabetes Care|June 18, 2011
Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History StudyJay M Sosenko, Jay S Skyler, Jeffrey Mahon, et al.
Diabetes Care|May 2, 2012
The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetesJay M Sosenko, Jay S Skyler, Jeffrey Mahon, et al.
Pageof 10